In the first patient study of the caspase 3/7-specific isatin sulphonamide PET radiotracer, we show that the lack of significant global tumour [18F]ICMT-11 dependent PET changes, despite some regional voxel changes, reflect a lack of significant apoptosis induction following chemotherapy. The gene discussed is CASP3; the disease is neoplasm.